I-SHP2

CAT # Igama lemveliso Inkcazo
CPD100391 SHP394
CPD100390 SHP389 (isiseko sasimahla)
CPD3242 RMC-4550 I-RMC-4550 yi-SHP2 inhibitor enamandla kwaye ekhethiweyo. I-RMC-4550 ichongiwe njengekhompawundi yesixhobo somgangatho ophezulu wokufunda indima ye-SHP2 kwi-tumor biology, zombini kwi-vitro nakwi-vivo kwiimpuku. I-SHP2 yindawo yomqondiso eguqukayo kunye nothintelo lwe-SHP2 luyasebenza ekujoliseni zombini phezulu (eqhutywa yi-RTK) kunye nasezantsi (i-RAS-GTP exhomekeke) kwiinguqu kwindlela ye-RAS-MAPK.

Qhagamshelana nathi

Ukubuza

Iindaba zamva

  • Iindlela eziPhezulu ze-7 kuPhando lwezoPhando kwi-2018

    IiNdlela ezi-7 eziphambili kuPhando lwaMayeza...

    Ukuba phantsi koxinzelelo oluhlala lukhula lokukhuphisana kwimeko yezoqoqosho kunye nethekhinoloji ecela umngeni, iinkampani zamayeza kunye nebhayoloji kufuneka ziqhubeke zenza izinto ezintsha kwiinkqubo zazo zeR&D ukuze zihlale phambili ...

  • I-ARS-1620: I-inhibitor entsha ethembisayo ye-KRAS-mutant cancers

    I-ARS-1620: Isithinteli esitsha esithembisayo se-K...

    Ngokophononongo olupapashwe kwiSeli, abaphandi baye baphuhlisa inhibitor ethile ye-KRASG12C ebizwa ngokuba yi-ARS-1602 ebangele ukuhlehla kwethumba kwiimpuku. "Olu phononongo lubonelela ngobungqina bokuba i-KRAS eguqukayo inokuba...

  • I-AstraZeneca ifumana unyuso lolawulo lwamachiza e-oncology

    I-AstraZeneca ifumana unyuso lolawulo lwe...

    I-AstraZeneca ifumene ukongezwa okuphindwe kabini kwipotfoliyo yayo ye-oncology ngoLwesibini, emva kokuba abalawuli base-US naseYurophu bamkele ukungeniswa kolawulo lwamachiza ayo, inyathelo lokuqala lokuphumelela ukuvunywa kwala mayeza. ...

Incoko ka-WhatsApp kwi-Intanethi!